Gilead Sciences (GILD) Change in Cash (2009 - 2026)

Gilead Sciences (GILD) has reported Change in Cash for 18 consecutive years, with -$4.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash fell 59.9% year-over-year to -$4.4 billion; the trailing twelve-month figure through Jun 2026 stood at -$2.0 billion (down 182.88% YoY), and the FY2025 full-year result was -$2.4 billion, down 162.16% from the prior year.
• Change in Cash retreated to -$4.4 billion in Q2 2026 per GILD's latest filing, from $65.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $5.0 billion in Q4 2024 and bottomed at -$4.4 billion in Q2 2026.
• Historically, Change in Cash has averaged -$120.0 million across 5 years, with a median of $33.0 million in 2023.
• The widest YoY moves for Change in Cash: up 226300.0% in 2024, down 353.39% in 2024.
• Over 5 years, Change in Cash stood at $713.0 million in 2022, then slumped by 46.7% to $380.0 million in 2023, then jumped by 1203.95% to $5.0 billion in 2024, then plunged by 95.3% to $233.0 million in 2025, then slumped by 2009.87% to -$4.4 billion in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$4.4 billion, $65.0 million, and $233.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.